| Date Filed | Type | Description |
| 05/03/2011 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 04/19/2011 |
SC 13G/A
| CPEX Pharmaceuticals, Inc. reports a 0% stake in CPEX Pharmaceuticals, Inc. |
| 04/18/2011 |
SC 13G/A
| CPEX Pharmaceuticals, Inc. reports a 5.5% stake in CPEX Pharmaceuticals, Inc. |
| 04/05/2011 |
8-K
| Quarterly results |
| 04/05/2011 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 04/05/2011 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 04/05/2011 |
BW
| CPEX Completes Sale to FCB I Holdings |
| 04/05/2011 |
SC 13G
| CPEX Pharmaceuticals, Inc. reports a 12% stake in CPEX Pharmaceuticals, Inc. |
| 04/05/2011 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 03/31/2011 |
10-K
| Annual Report for the period ended December 31, 2010 |
| 03/30/2011 |
8-K
| Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits |
| 03/24/2011 |
BW
| CPEX Stockholders Approve $27.25 Per Share Merger Agreement with FCB I Holdings |
| 03/23/2011 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 03/23/2011 |
BW
| CPEX Urges Stockholders to Consider the Facts of the Certain All-Cash FCB Transaction |
| 03/22/2011 |
PRN
| Mangrove Partners Notes CPEX Stock Trading Above Offer Price |
| 03/21/2011 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 03/21/2011 |
PRN
| Mangrove Partners Expresses Disappointment in Board of CPEX Pharmaceuticals, Inc. and Reaffirms Proposed Recapitalization and Intention to Vote Against Merger |
| 03/18/2011 |
8-K
| Other Events, Financial Statements and Exhibits |
| 03/18/2011 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 03/18/2011 |
BW
| CPEX Pharmaceuticals Affirms Recommendation That Stockholders Vote for Merger Agreement With FCB |
| 03/17/2011 |
8-K
| Other Events, Financial Statements and Exhibits |
| 03/17/2011 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 03/17/2011 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 03/17/2011 |
SC 13D/A
| CPEX Pharmaceuticals, Inc. reports a 6.3% stake in CPEX Pharmaceuticals, Inc. |
| 03/17/2011 |
BW
| CPEX Pharmaceuticals Advises Stockholders to Take No Action at This Time in Response to Mangrove Partners' Revised Proposal |
| 03/17/2011 |
BW
| CPEX Pharmaceuticals Continues to Recommend That Stockholders Vote for the Merger Agreement with FCB |
| 03/17/2011 |
SC 13D/A
| Mangrove Partners Fund, L.P. reports a 5.7% stake in CPEX Pharmaceuticals, Inc. |
| 03/15/2011 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 03/15/2011 |
8-K
| Form 8-K - Current report |
| 03/15/2011 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 03/15/2011 |
BW
| CPEX Pharmaceuticals Advises Stockholders to Take No Action at This Time in Response to Mangrove Partners' Proposal |
| 03/14/2011 |
SC 13D/A
| Mangrove Partners Fund, L.P. reports a 5.7% stake in CPEX Pharmaceuticals, Inc. |
| 03/14/2011 |
PRN
| Mangrove Partners Proposes Fully-Financed Dividend Recapitalization to Board of CPEX Pharmaceuticals, Inc. |
| 03/11/2011 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
|